Item

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: A population-based analysis

van Herk-Sukel,M.P.P.
; 
van de Poll-Franse,L.V.
; 
Voogd,A.C.
; 
Nieuwenhuijzen,G.A.P.
; 
Coebergh,J.W.W.
; 
Herings,R.M.C.
Abstract
Description
Date
2010
Journal Title
Journal ISSN
Volume Title
Publisher
Collections
Tilburg University Research Output Collection
Show all metadata
Files
Half.pdf
Adobe PDF, 265.67 KB
Research Projects
Organizational Units
Journal Issue
Keywords
SDG 3 - Good Health and Well-being
Citation
van Herk-Sukel, M P P, van de Poll-Franse, L V, Voogd, A C, Nieuwenhuijzen, G A P, Coebergh, J W W & Herings, R M C 2010, 'Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years : A population-based analysis', Breast Cancer Research and Treatment, vol. 122, no. 3, pp. 843-851.
URI
https://hdl.handle.net/20.500.14602/54782
Embedded videos